Corrigendum: Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus.

[This corrects the article on p. 592 in vol. 6, PMID: 26136733.].

In the original research article, Juan Wang and Zengping Gao were not included in the author list. They have now been included along with the affiliation: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

In addition, Zengping Gao has been included as a corresponding author.

Finally, the authors unintentionally did not acknowledge funding from the National Natural Science Foundation of China No.31270400.

The authors apologize for these oversights. These errors do not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.